Fetal Fentanyl Syndrome: Unveiling a New Syndrome Linked to Fentanyl Use During Pregnancy
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
The article highlights the entrepreneurs behind Face2Gene, an innovative decision-support tool revolutionizing genetic testing by making it faster and more affordable. Face2Gene leverages cutting-edge facial recognition technology and artificial intelligence to identify genetic disorders from patient photos. By analyzing facial features and comparing them with a vast database of genetic conditions, the tool provides quick and reliable diagnostic suggestions. This advancement significantly reduces the time and cost traditionally associated with genetic testing. The article emphasizes how Face2Gene‘s efficiency and accessibility are transforming genetic diagnostics, offering a crucial resource for early detection and personalized medical care.
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
Dr Giulia Pascolini, an esteemed Italian M.D. and Ph.D., is currently responsible for the Genetic Counselling Service of the Istituto…
Founded in 2017, the Spanish Coffin Siris Syndrome Association is an organization dedicated to supporting families affected by this rare…